Published in Proc Soc Exp Biol Med on November 01, 1967
Bovine lymphosarcoma. Adv Vet Sci Comp Med (1980) 1.54
Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin. J Natl Cancer Inst (1972) 1.51
Induction of syncytia by the bovine C-type leukemia virus. Cancer Res (1976) 1.41
Natural mode of transmission of the bovine leukemia virus: role of bloodsucking insects. Am J Vet Res (1978) 1.37
Studies on the relationship between infection with bovine C-type virus, leukemia, and persistent lymphocytosis in cattle. Cancer Res (1974) 1.37
Bovine leukosis: natural transmission and principles of control. J Am Vet Med Assoc (1979) 1.35
Postnatal and prenatal transmission of the bovine leukemia virus under natural conditions. J Natl Cancer Inst (1979) 1.34
Expression of the bovine leukemia virus and its internal antigen in blood lymphocytes. Proc Soc Exp Biol Med (1977) 1.29
Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice. Cancer Res (1969) 1.26
Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle. Science (1982) 1.21
In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures. Cancer Res (1976) 1.16
Serological detection of type C viruses found in bovine cultures. Cancer Res (1972) 1.16
Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances. Biochem J (1974) 1.15
Relationship between lymphosarcoma and persistent lymphocytosis in cattle: a review. J Am Vet Med Assoc (1979) 1.12
Diagnosis of bovine leukemia virus infection: evaluation of serologic and hematologic tests by a direct infectivity detection assay. Am J Vet Res (1977) 1.08
Antigenic characteristics of lymphomas induced by radiation leukemia virus (RadLV) in mice and rats. Cancer Res (1968) 1.07
Bovine leukemia virus genes in the DNA of leukemic cattle. Science (1976) 1.04
Role of the spleen in passive immunological enhancement. Transplantation (1968) 1.02
Milk of dairy cows frequently contains a leukemogenic virus. Science (1981) 1.02
Natural mode of transmission of the bovine C type leukemia virus (BLV). Bibl Haematol (1975) 1.02
Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle. J Virol (1984) 1.00
Prostaglandin modulation of development of cell-mediated immunity in culture. Nature (1980) 1.00
Comparison of various serological and direct methods for the diagnosis of BLV infection in cattle. Int J Cancer (1981) 1.00
Modification of tumor regression by immunologic means. Cancer Res (1969) 0.99
Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance. Int J Cancer (1996) 0.99
Transmission of bovine leukosis virus by blood inoculation. Am J Vet Res (1986) 0.98
Role of tumor necrosis factor in macrophage activation and tumoricidal activity. Cancer Res (1988) 0.97
Characterization of the blood lymphocyte population in cattle infected with the bovine leukemia virus. Cancer Res (1985) 0.96
Inhibition of the reverse transcriptase of bovine leukemia virus by antibody in sera from leukemic cattle and immunological characterization of the enzyme. Cancer Res (1977) 0.95
Induction of lymphosarcoma in sheep by bovine leukemia virus. J Natl Cancer Inst (1981) 0.94
Persistent lymphocytosis in cattle: its cause, nature and relation to lymphosarcoma. Ann Rech Vet (1978) 0.94
An evaluation of the role of milk in the natural transmission of BLV. Ann Rech Vet (1978) 0.94
Development of an in vitro infectivity assay for the C-type bovine leukemia virus. Cancer Res (1976) 0.93
Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon. Cancer Res (1987) 0.93
Seroepidemiological evidence for horizontal transmission of bovine C-type virus. Cancer Res (1975) 0.93
Role of colostrum and milk in the natural transmission of the bovine leukemia virus. Cancer Res (1981) 0.92
Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha. Cancer Res (1992) 0.91
Development and evaluation of a highly sensitive and specific blocking enzyme-linked immunosorbent assay and polymerase chain reaction assay for diagnosis of bovine leukemia virus infection in cattle. Am J Vet Res (2001) 0.90
Detection of replicating C-type viruses in continuous cell cultures established from cows with leukemia: effect of the culture medium. J Natl Cancer Inst (1971) 0.89
Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. Cancer Res (1978) 0.89
Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. Cancer Res (1989) 0.89
Adriamycin-induced modulation of host defenses in tumor-bearing mice. Cancer Res (1992) 0.88
A critical comparison of the virus neutralizaiton, radioimmunoprecipitation and immunodiffusion tests for the serological diagnosis of BLV infection. Ann Rech Vet (1978) 0.88
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice. Cancer Res (1977) 0.88
Effects of anticancer drugs on the immune system in humans. Semin Oncol (1989) 0.88
Isolation and characterization of an antigen of the bovine C-type virus. Cancer Res (1976) 0.88
Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int J Cancer (1994) 0.88
Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential. Recent Results Cancer Res (1982) 0.87
Immunosuppressive effects of methylglyoxal-bis(guanylhydrazone) on mouse bone marrow and spleen cells and their antagonism by spermidine. Biochem Pharmacol (1978) 0.87
Detection, quantitation, and characterization of the major internal virion antigen of the bovine leukemia virus by radioimmunoassay. J Natl Cancer Inst (1976) 0.87
Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice. Int J Cancer (2000) 0.87
Host soluble factors with blocking and stimulating activity on the expression of the bovine leukemia virus. J Infect Dis (1994) 0.87
Detection of a precursor-like protein of bovine leukaemia virus structural polypeptides in purified virions. J Gen Virol (1980) 0.87
Induction and inhibition of bovine leukaemia virus expression in naturally infected cells. J Gen Virol (1992) 0.87
Toxicological and antiproliferative effects of N6-(delta2-isopentenyl) adenosine, a natural component of mammalian transfer RNA. Cancer Res (1970) 0.87
Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specific. Infect Immun (1981) 0.86
Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice. Cancer Res (1986) 0.86
Antigenic comparison of bovine type C virus with murine and feline leukemia viruses. Cancer Res (1972) 0.86
A novel tumor necrosis factor-alpha inhibitory protein, TIP-B1. Int J Immunopharmacol (2000) 0.85
Doxorubicin-induced DNA degradation in murine thymocytes. Mol Pharmacol (1994) 0.85
Modification of host antitumor defense mechanisms in mice by progressively growing tumor. Cancer Res (1989) 0.85
Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts. Cancer Res (1986) 0.84
Phytohemagglutinin activation of the transcription of the bovine leukemia virus genome requires de novo protein synthesis. J Virol (1985) 0.84
Erythroleukemia in two infant chimpanzees fed milk from cows naturally infected with the bovine C-type virus. Cancer Res (1974) 0.84
Further studies on the antigenic properties and distribution of the putative bovine leukemia virus. Bibl Haematol (1975) 0.83
Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunol Immunother (1998) 0.83
Detection, purification, and characterization of two species of covalently closed circular proviral DNA molecules of bovine leukemia virus. J Virol (1983) 0.83
Molecular cloning of covalently closed circular DNA of bovine leukemia virus. J Virol (1984) 0.83
Amplification and analysis of specific DNA and RNA sequences of bovine leukemia virus from infected cows by polymerase chain reaction. J Clin Microbiol (1992) 0.83
Expression, tissue distribution, and cellular localization of the antiapoptotic TIP-B1 protein. J Leukoc Biol (2001) 0.83
Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses. Int J Cancer (1973) 0.82
Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. Cancer Res (1975) 0.82
Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells. Int J Immunopharmacol (1982) 0.81
The clinical toxicity of anticancer drugs and its prediction. Semin Oncol (1977) 0.81
Adriamycin induced immunomodulation: dependence upon time of administration. Int J Immunopharmacol (1983) 0.81
Effect of splenectomy on the regression of transplantable tumors. Cancer Res (1968) 0.81
Concomitant loss of specific cell-surface antigen and demonstrable type-C virus particles in lymphomas induced by radiation leukemia virus in rats. J Natl Cancer Inst (1969) 0.81
Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin. Cancer Res (1988) 0.81
Modulation of the development of cell-mediated immunity: possible role of the products of the cyclo-oxygenase and the lipoxygenase pathways of arachidonic acid metabolism. Int J Immunopharmacol (1982) 0.81
The phenomenon of polykaryocytosis induced by BLV in mixed cultures: specificity, mechanisms and application to the diagnosis of BLV infection in cattle. Ann Rech Vet (1978) 0.81
The trans-activating C-type retroviruses share a distinct epitope(s) that induces antibodies in certain infected hosts. J Gen Virol (1991) 0.80
Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2. Cancer Immunol Immunother (1996) 0.80
Experimental transmission of bovine leukosis virus by simulated rectal palpation. Vet Rec (1988) 0.80
Cyclophosphamide plus tumor necrosis factor-alpha chemoimmunotherapy cured mice: life-long immunity and rejection of re-implanted primary lymphoma. Int J Cancer (1995) 0.80
Enhancement of the growth of sarcoma 180 in splenectomized and sham-operated AKR mice. Transplantation (1968) 0.80
Use of a feline cell line in the syncytia infectivity assay for the detection of bovine leukemia virus infection in cattle. Am J Vet Res (1981) 0.80
Notification to readers. Expression of bovine leukemia virus genome is blocked by a nonimmunoglobulin protein in plasma from infected cattle. Science (1989) 0.80
Plasma membrane as a site for chemotherapeutic intervention. Adv Enzyme Regul (1978) 0.80
Expansion of clonotypic T-cell populations in the peripheral blood of asymptomatic Gran Chaco Amerindians infected with HTLV-IIB. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.80
Antigenic differences between leukemia L1210 and a subline resistant to methylglyoxal-bis(guanylhydrazone). Cancer Res (1972) 0.80
Changes in cytosolic and membrane TNF inhibitory protein-B1 (TIP-B1) levels associated with protection from TNF-induced cytotoxicity. FASEB J (2001) 0.79
Comparison of adriamycin induced immunomodulation with that of the noncardiotoxic anthracycline 5-iminodaunorubicin. Int J Immunopharmacol (1988) 0.79
Recent electron microscopic and immunologic studies on bovine cell cultures containing C-type viruses. Bibl Haematol (1973) 0.79
An infectivity assay for the bovine leukemia virus based on the induction of the major internal virion antigen in susceptible cell cultures. Ann Rech Vet (1978) 0.79
Serological diagnosis of infection with the putative bovine leukemia virus. Cornell Vet (1975) 0.79
Comparative study of the toxicologic effects of 7-deazaadenosine (tubercidin) and 7-deazainosine. Cancer Res (1969) 0.79
Toxic and patologic effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone), a new antileukemic agent. Cancer Res (1969) 0.79